IP Library Granted Patent US 7,427,416
Granted Patent B2
US 7,427,416 · App. 10/690,724 · Granted Sep 23, 2008

Methods of treating conditions using metal-containing materials

Assignee: Nucryst Pharmaceuticals Corp.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,427,416
App. No.
10/690,724
Granted
Sep 23, 2008
Kind
B2
Abstract

Methods of treating conditions using metal-containing materials are disclosed. Exemplary conditions include bacterial conditions, biofilm conditions, microbial conditions, inflammatory conditions, fungal conditions, viral conditions, autoimmune conditions, idiopathic conditions, hyperproliferative conditions, noncancerous growths, cancerous conditions and combinations of such conditions. In certain embodiments, the metal-containing material is an atomically disordered, nanocrystalline silver-containing material.

Claims (12)

1. A method of treating a subject having a condition, comprising:

contacting an area of the subject having the condition with an effective amount of a nanocrystalline material that comprises:

a metal selected from the group consisting of silver, platinum and palladium; and

an element selected from the group consisting of oxygen, nitrogen, carbon, boron, sulfur, a halogen, phosphorus, silicon, hydrogen and combinations thereof, wherein:

the nanocrystalline material is in a suppository or an enema,

the nanocrystalline material contains at least about one atomic percent of the element, and

the condition is inflammatory bowel disease.

2. The method of claim 1 , wherein the metal is silver.

3. The method of claim 1 , wherein the nanocrystalline material is in a suppository.

4. The method of claim 1 , wherein the nanocrystalline material is in an enema.

5. The method of claim 3 , wherein the metal is silver.

6. The method of claim 4 , wherein the metal is silver.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 17, 2004
From: GILLIS, SCOTT H.; SCHECHTER, PAUL; STILES, JAMES
To: NUCRYST PHARMACEUTICALS CORP.
Reel/Frame 015094/0264 →
Continuity (19)
Continuation In Part 0991675700 · Jul 27, 2001
Continuation In Part 0962873500 · Jul 27, 2000
Continuation In Part 1015958700 · May 30, 2002
Continuation In Part 1013156800 · Apr 23, 2002
Continuation In Part 0984063700 · Apr 23, 2001
Continuation In Part 1013151100 · Apr 23, 2002
Continuation In Part 0984063700 · Apr 23, 2001
Continuation In Part 1013150900 · Apr 23, 2002
Continuation In Part 0984063700 · Apr 23, 2001
Continuation In Part 1012820800 · Apr 23, 2002
Continuation In Part 0984063700 · Apr 23, 2001
Continuation In Part 1027767300 · Oct 22, 2002
Continuation In Part 1027735600 · Oct 22, 2002
Continuation In Part 1027729800 · Oct 22, 2002
Continuation In Part 1027736200 · Oct 22, 2002
Continuation In Part 1027735800 · Oct 22, 2002
Continuation In Part 1027732000 · Oct 22, 2002
Provisional Application 6028588400 · Apr 23, 2001
Related Publication 20040131698A1 · Jul 8, 2004